Top Markets
Coin of the day
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Rank in Stocks #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Share Price
$27.75
Market Cap
$7.84B
Change (1 day)
6.21%
Change (1 year)
-27.88%
Country
US
Trade Caris Life Sciences, Inc. (CAI)

Category

Price of CAI with the market cap of B
Caris Life Sciences, Inc. Caris Life Sciences, Inc.
CAI
$27.75
Market Capitalization of Caris Life Sciences, Inc.(CAI)
Market Cap: $7.84B
As of August 2026 Caris Life Sciences, Inc. has a market cap of $7.84B. This makes Caris Life Sciences, Inc. the world's 2605th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Caris Life Sciences, Inc. from 2025 to 2026
CAI compared with Top 5 Most Popular stocks
Price of CAI Asset B Mkt. of B Results
Caris Life Sciences, Inc. Caris Life Sciences, Inc.
$18,227.20 $7.84B
$5.152T +65,579.34%
Caris Life Sciences, Inc. Caris Life Sciences, Inc.
$16,049.95 $7.84B
$4.537T +57,733.92%
Caris Life Sciences, Inc. Caris Life Sciences, Inc.
$14,746.53 $7.84B
$4.169T +53,037.21%
Caris Life Sciences, Inc. Caris Life Sciences, Inc.
$12,885.01 $7.84B
$3.642T +46,329.46%
Caris Life Sciences, Inc. Caris Life Sciences, Inc.
$9,921.79 $7.84B
$2.805T +35,651.88%